Hims & Hers launches Wegovy knockoff pill
Digest more
By Anusha Shah and Amina Niasse Feb 7 (Reuters) - Online telehealth company Hims & Hers on Saturday reversed course on its ...
Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved ...
Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with ...
Hims & Hers Health Inc. announced it will stop selling a copycat version of Novo Nordisk's Wegovy weight-loss pill two days ...
By Maggie Fick and Bhanvi Satija LONDON, Feb 6 (Reuters) - Hims & Hers' gambit to sell a $49 compounded version of Novo ...
By comparison, Novo Nordisk’s Wegovy pill—launched earlier this year and already used by more than 170,000 people, CEO Mike ...
Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced an expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results